John E. Sulston

  Sir John Edward Sulston PhD, FRS (born March 27, 1942) was educated at Pembroke College, Cambridge graduating in 1963. He joined the Chemistry Department in Cambridge, gained his PhD for research in nucleotide chemistry and devoted his scientific life to biological research, especially in the field of molecular biology. After working as a Postdoctoral researcher at the Salk Institute, USA for a while, he returned to Cambridge to work under Sydney Brenner at the MRC Laboratory of Molecular Biology.

Additional recommended knowledge

Daily Visual Balance Check

What is the Correct Way to Check Repeatability in Balances?

Daily Sensitivity Test

Sulston played a central role in both the Caenorhabditis elegans worm and human genome sequencing projects. He had argued successfully for the sequencing of C. elegans to show that large-scale genome sequencing projects were feasible. As sequencing of the worm genome proceeded, the project to sequence the human genome began. At this point he was made director of the newly established Sanger Centre (named after Fred Sanger and now the Wellcome Trust Sanger Institute), located in Cambridgeshire, UK.

Following completion of the ' working draft ' of the human genome sequence in 2000, Sulston retired from his role as director at the Sanger Centre. In 2002 he shared the Nobel Prize in Physiology or Medicine with Sydney Brenner and H. Robert Horvitz, both of whom he had collaborated with at the Cambridge Laboratory of Molecular Biology (LMB). One of Sulston's most important contributions during his research years at the LMB was to elucidate the precise order in which cells in C. elegans divide. In fact, he and his team succeeded in tracing the nematode's entire embryonic cell lineage. Sulston is now a leading campaigner against the patenting of human genetic information. John E. Sulston was also a co-author of articles on the new Public Library of Science journal.

In 2007 it was announced that Sulston will join The University of Manchester's Faculty of Life Sciences and will chair Institute of Science, Ethics and Innovation, a new research institute focusing on the ethical questions raised by science and technology in the 21st century.

See also

• Apoptosis
• History and highlights in apoptosis research